Raymond James Financial
NUVB icon

Raymond James Financial’s Nuvation Bio NUVB Stock Holding History

Raymond James Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Buy
62,940
+2,269
+4% +$12.6K ﹤0.01% 4715
2025
Q4 		$544K Sell
60,671
-3,425
-5% -$21.2K ﹤0.01% 4214
2025
Q3 		$237K Buy
64,096
+49,677
+345% +$135K ﹤0.01% 4531
2025
Q2 		$28.1K Sell
14,419
-9,243
-39% -$19.3K ﹤0.01% 5446
2025
Q1 		$41.6K Buy
+23,662
New +$53.9K ﹤0.01% 4653

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial's NUVB Position: Q1 2026 in Review

Raymond James Financial increased its Nuvation Bio (NUVB) stake by 3.7% in Q1 2026, buying an estimated $12.6K and bringing the position to 62,940 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #4715.

Raymond James Financial first reported a position in NUVB in Q1 2025 and has held it in 5 quarters since. The position peaked at $544K in Q4 2025. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Raymond James Financial held 62,940 shares of Nuvation Bio worth $270K as of Q1 2026.
  • Raymond James Financial bought 2,269 Nuvation Bio shares in Q1 2026, an estimated $12.6K.
  • Nuvation Bio made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4715 holding.
  • Raymond James Financial first reported a position in Nuvation Bio in Q1 2025 and has held it in 5 quarters since.
  • Raymond James Financial's Nuvation Bio position peaked at $544K in Q4 2025.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.